Want to join the conversation?
$MRK, which competes with rivals $GSK and $PFE, said it expects FY16 GAAP EPS to be in the range of $1.96-2.23. $MRK narrowed and raised its FY16 non-GAAP EPS to be between $3.65-3.77, including an approx. 2% negative impact from FX at mid-April exchange rates. At mid-April exchange rates, $MRK now anticipates FY16 revenues between $39-40.2Bil.
Looking forward to the first $TSLA earnings after SolarCity acquisition.
What will be an ideal EPS range for $PZZA in its earnings today?